Clinical Trial

Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2026 (before its estimated August 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-11.
Trial Details
NCT Number NCT06935071
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Hip Fractures, Hip Fracture Pathologic, Pathological Fracture, Pathological Fracture of Hip
Enrollment 300 participants
Start Date 2016-08-04
Primary Completion 2026-08-04 (estimated)
Study Completion 2026-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-16